Home LiteratureArticle Details
PMID: 8627668 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Journal of virology ·Vol. 70 ·No. 3 ·1996-03-00 ·Pages 1505-11

Aldrovandi GM, Zack JA

Abstract

The functional roles of the human immunodeficiency virus type 1 (HIV-1) accessory genes (nef, vpr, vpu, and vif) are as yet unclear. Using the SCID-hu model system, we have examined the infectivity, replicative capacity, and pathogenicity of strains of the molecular clone HIV-1NL4-3 that contain deletion mutations in these individual accessory genes. We determined that deletion of these genes had differential effects on both infectivity and pathogenicity. Deletion of vpr had little or no effect on viral infectivity, replication, and pathogenicity; however, deletion of vpu or vif had a significant effect on infectivity and moderate effects on pathogenicity. nef-minus strains were the most attenuated in this system, demonstrating significantly lower levels of infectivity and pathogenicity. However, deletion of these individual genes attenuated but did not abrogate the pathogenic properties of HIV-1. Mutant viruses still retained the ability to induce thymocyte depletion to various degrees if implants were infected with higher doses of virus or observed for longer periods of time. The relative contributions of these genes to in vivo pathogenic potential should be taken into consideration when one is contemplating a live attenuated vaccine for HIV-1.

MeSH Terms
Animals Base Sequence Cell Line DNA, Viral Disease Models, Animal Gene Deletion Gene Products, nef/genetics Gene Products, vif/genetics Gene Products, vpr/genetics Genes, Viral HIV-1/genetics,pathogenicity,physiology Human Immunodeficiency Virus Proteins Humans Mice Mice, SCID Molecular Sequence Data Viral Regulatory and Accessory Proteins/genetics Virus Replication nef Gene Products, Human Immunodeficiency Virus vif Gene Products, Human Immunodeficiency Virus vpr Gene Products, Human Immunodeficiency Virus
Chemicals
DNA, Viral Gene Products, nef Gene Products, vif Gene Products, vpr Human Immunodeficiency Virus Proteins Viral Regulatory and Accessory Proteins nef Gene Products, Human Immunodeficiency Virus vif Gene Products, Human Immunodeficiency Virus vpr Gene Products, Human Immunodeficiency Virus vpu protein, Human immunodeficiency virus 1
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Aldrovandi G M
Department of Medicine, UCLA School of Medicine, USA.
Zack J A
References (52)
52 references, click to expand
  1. Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
    Cell. 1991 May 17;65(4):651-62 PMID: 2032289
  2. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
    Cell. 1990 Apr 20;61(2):213-22 PMID: 2331748
  3. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women.
    Pediatrics. 1992 Feb;89(2):297-301 PMID: 1734399
  4. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle.
    J Virol. 1992 Mar;66(3):1717-25 PMID: 1371173
  5. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.
    J Virol. 1992 Oct;66(10):6213-9 PMID: 1527859
  6. Cell-free transmission of Vif mutants of HIV-1.
    Virology. 1992 Sep;190(1):19-29 PMID: 1529528
  7. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    J Virol. 1992 Nov;66(11):6489-95 PMID: 1357189
  8. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.
    Science. 1992 Dec 18;258(5090):1938-41 PMID: 1470917
  9. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.
    J Virol. 1993 Feb;67(2):902-12 PMID: 8380472
  10. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles.
    J Virol. 1993 Mar;67(3):1663-6 PMID: 8437236
  11. Human immunodeficiency virus vpr product is a virion-associated regulatory protein.
    J Virol. 1990 Jun;64(6):3097-9 PMID: 2139896
  12. Long-term human hematopoiesis in the SCID-hu mouse.
    J Exp Med. 1990 Oct 1;172(4):1055-63 PMID: 2212942
  13. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.
    Proc Natl Acad Sci U S A. 1990 Oct;87(20):8080-4 PMID: 2236020
  14. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.
    Nature. 1991 Apr 11;350(6318):508-11 PMID: 2014052
  15. Induction of cell differentiation by human immunodeficiency virus 1 vpr.
    Cell. 1993 Feb 26;72(4):541-50 PMID: 8440020
  16. HIV induces thymus depletion in vivo.
    Nature. 1993 Jun 24;363(6431):728-32 PMID: 8100043
  17. The SCID-hu mouse as a model for HIV-1 infection.
    Nature. 1993 Jun 24;363(6431):732-6 PMID: 8515816
  18. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    J Virol. 1993 Aug;67(8):4945-55 PMID: 8331734
  19. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.
    J Virol. 1993 Oct;67(10):6322-6 PMID: 8371360
  20. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.
    J Exp Med. 1993 Oct 1;178(4):1151-63 PMID: 8376927
  21. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.
    J Virol. 1993 Dec;67(12):7238-45 PMID: 8230446
  22. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
    J Exp Med. 1994 Jan 1;179(1):101-13 PMID: 8270859
  23. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.
    J Exp Med. 1994 Jan 1;179(1):115-23 PMID: 7903679
  24. Selective thymocyte depletion in neonatal HIV-1 thymic infection.
    AIDS. 1993 Dec;7(12):1601-5 PMID: 8286069
  25. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.
    J Exp Med. 1994 Feb 1;179(2):513-22 PMID: 8294863
  26. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
    J Virol. 1994 Mar;68(3):1926-34 PMID: 8107252
  27. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.
    J Virol. 1994 May;68(5):2906-14 PMID: 8151761
  28. Role of vif during packing of the core of HIV-1.
    Virology. 1994 Jun;201(2):349-55 PMID: 8184544
  29. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.
    J Virol. 1994 Jun;68(6):3478-85 PMID: 8189487
  30. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.
    Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7311-5 PMID: 8041786
  31. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes.
    AIDS Res Hum Retroviruses. 1994 Apr;10(4):343-50 PMID: 8068414
  32. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4.
    Virology. 1994 Oct;204(1):357-66 PMID: 8091666
  33. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.
    J Virol. 1995 Feb;69(2):882-8 PMID: 7815556
  34. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    J Virol. 1995 Apr;69(4):2058-67 PMID: 7884851
  35. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
    J Virol. 1995 Apr;69(4):2068-74 PMID: 7884852
  36. Progression to AIDS in the absence of a gene for vpr or vpx.
    J Virol. 1995 Apr;69(4):2378-83 PMID: 7884883
  37. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
    Science. 1995 Mar 24;267(5205):1820-5 PMID: 7892606
  38. vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys.
    J Virol. 1995 Aug;69(8):4807-13 PMID: 7609047
  39. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    J Virol. 1995 Aug;69(8):5048-56 PMID: 7541845
  40. Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.
    J Virol. 1995 Sep;69(9):5883-9 PMID: 7637036
  41. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys.
    Cell. 1995 Aug 25;82(4):665-74 PMID: 7664345
  42. In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates.
    J Virol. 1995 Oct;69(10):6259-64 PMID: 7666526
  43. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.
    J Virol. 1995 Oct;69(10):6304-13 PMID: 7666531
  44. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.
    J Virol. 1995 Nov;69(11):6705-11 PMID: 7474080
  45. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.
    J Virol. 1995 Nov;69(11):6859-64 PMID: 7474100
  46. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
    J Virol. 1995 Nov;69(11):7032-44 PMID: 7474123
  47. The HIV 'A' (sor) gene product is essential for virus infectivity.
    Nature. 1987 Aug 20-26;328(6132):728-30 PMID: 2441266
  48. The sor gene of HIV-1 is required for efficient virus transmission in vitro.
    Science. 1987 Aug 21;237(4817):888-93 PMID: 3497453
  49. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product.
    Nature. 1987 Nov 19-25;330(6145):266-9 PMID: 3118220
  50. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.
    Science. 1988 Sep 23;241(4873):1632-9 PMID: 2971269
  51. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein.
    J Virol. 1989 Sep;63(9):3784-91 PMID: 2788224
  52. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA.
    Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5326-30 PMID: 2052609
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-03-00
Pages
1505-11
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC189971
Subset
IM
Grants
NIAID NIH HHS · AI28697 · United States
NIAID NIH HHS · AI36059 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com